ALT5 Sigma (ALTS) director receives 10,000-share grant and makes 10,000-share purchase
Rhea-AI Filing Summary
Director David C. Danziger reported two stock transactions in ALT5 Sigma Corp (ALTS). On 07/02/2025 he was granted 10,000 shares of common stock at a reported price of $7.88, noted as a grant tied to his appointment to the board. Following that transaction his beneficial ownership was reported as 20,000 shares. A subsequent transaction on 08/14/2025 shows an additional 10,000 shares acquired at $7.30, keeping reported beneficial ownership at 20,000 shares. The Form 4 is signed and dated 10/09/2025, and the filer checked that the form was filed by one reporting person.
Positive
- 10,000-share grant was issued upon board appointment on 07/02/2025
- Additional 10,000-share acquisition on 08/14/2025 increased the director's direct stake
Negative
- None.
Insights
New director received 10,000-share grant when appointed and later acquired 10,000 shares.
The disclosure shows a 10,000-share grant on 07/02/2025 tied to the reporting person's board appointment and a separate acquisition of 10,000 shares on 08/14/2025. Both transactions are reported as acquisitions and the filing lists total beneficial ownership as 20,000 shares after each event.
Governance implications are straightforward: the equity grant aligns the director's interests with shareholders and the later purchase increases direct stake. Monitor future Section 16 filings for any disposal codes or option grants that would change ownership or signal further compensation arrangements within the next 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $7.30 | $73K |
| Grant/Award | Common Stock | 10,000 | $7.88 | $79K |
Footnotes (1)
- F1. Common stock granted on date Mr. Danziger was added as a board member.
AI-generated analysis. How Rhea-AI works. Not financial advice.